Related Experiment Video
Updated: Jul 16, 2026

08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
Hepatic gene expression and lipid parameters in complement C3(-/-) mice that do not develop ethanol-induced steatosis
Igor Bykov1, Matti Jauhiainen, Vesa M Olkkonen
1National Public Health Institute, Departments of Mental Health and Alcohol Research, Finland.
Journal of Hepatology
|February 27, 2007
Summary
Complement factor C3 deficiency protects against alcohol-induced fatty liver disease by altering lipid metabolism. C3-deficient mice showed reduced steatosis, suggesting a role for complement in liver injury.
Area of Science:
- Hepatology
- Immunology
- Metabolic research
Background:
- Alcohol-induced fatty liver disease (steatosis) is a significant health concern.
- Complement component C3 plays a role in lipid metabolism.
- Previous observations indicated absence of ethanol-induced steatosis in C3-deficient mice.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying the protective effect of C3 deficiency against ethanol-induced liver steatosis.
- To analyze lipid parameters and gene expression profiles in C3-deficient and normal mice exposed to ethanol.
Main Methods:
- Feeding C3(+/+) and C3(-/-) mice a high-fat diet with ethanol or carbohydrates for 6 weeks.
- Analysis of serum and liver lipid parameters.
- Microarray and RT-PCR analysis of liver mRNA expression patterns.
Main Results:
- Ethanol reduced serum cholesterol, apoA-I, and PLTP activity in both genotypes.
- Ethanol increased serum and liver adiponectin in C3(-/-) mice.
- Ethanol altered lipogenic enzyme expression and phospholipase D1 in C3(-/-) mice, but not C3(+/+) mice.
Conclusions:
- Ethanol-induced alterations in lipid metabolism in C3(-/-) mice contribute to protection against fatty infiltration.
- These findings suggest a crucial interaction between complement factor C3 and lipid regulators in the pathogenesis of alcohol-induced steatosis.
- C3 deficiency may protect against subsequent inflammatory processes in the liver.

